Related Experiment Videos

Study of burn sepsis with special reference to Pseudomonas aeruginosa

C N Nagesha1, K J Shenoy, M R Chandrashekar

  • 1Department of Microbiology, Dr BR Ambedkar Medical College, Bangalore.

Insights

Pseudomonas aeruginosa was the most common burn wound infection, particularly in deep and major burns. Silver sulphadiazine showed antimicrobial action, unlike cerium sulphadiazine.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Burn Care

Background:

  • Burn wounds are susceptible to microbial colonization and infection.
  • Pseudomonas aeruginosa (Ps aeruginosa) is a common pathogen in burn infections.
  • Identifying prevalent microorganisms is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the microbiological profile of burn wound infections.
  • To determine the incidence and common sites of infection.
  • To evaluate the efficacy of different silver-based antimicrobial agents.

Main Methods:

  • Clinical and microbiological analysis of 50 burn cases.
  • Isolation and identification of bacterial and fungal pathogens.
  • Assessment of antimicrobial activity of silver sulphadiazine, cerium sulphadiazine, and zinc sulphadiazine.

Main Results:

  • Pseudomonas aeruginosa was the most frequent isolate (80.0%), followed by Staphylococcus pyogenes (16.0%).
  • Infection rates reached 100%, with Ps aeruginosa being dominant on admission and after hospitalization.
  • Deep and major burns showed higher infection incidence; Ps aeruginosa was prevalent in lower body burns, and Staph pyogenes in upper body burns.
  • Silver sulphadiazine demonstrated antimicrobial activity against Ps aeruginosa, while cerium sulphadiazine was ineffective. Zinc sulphadiazine showed moderate efficacy.

Conclusions:

  • Pseudomonas aeruginosa is a primary pathogen in burn wound infections, especially in severe burns.
  • Topical silver sulphadiazine remains a viable treatment option, whereas cerium sulphadiazine lacks efficacy.
  • Comprehensive microbiological surveillance and targeted antimicrobial therapy are essential for managing burn infections.

Related Concept Videos